Signet Ring Cell Carcinoma of the Stomach Is Significantly Associated with Poor Prognosis and Diffuse Gastric Cancer (Lauren’s): Single-Center Experience of 160 Cases-Reference-Cited by-同舟云学术

Signet Ring Cell Carcinoma of the Stomach Is Significantly Associated with Poor Prognosis and Diffuse Gastric Cancer (Lauren’s): Single-Center Experience of 160 Cases

Published:2011 Issue:12 Volume:34 Page:682-686
ISSN:1423-0240
Container-title:Onkologie
language:en
Short-container-title:Onkologie

Author:

Hass Holger G.,Smith Ute,Jäger Christina,Schäffer Michael,Wellhäußer Ulrich,Hehr Thomas,Markmann Hans-Ulrich,Nehls Oliver,Denzlinger Claudio

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference20 articles.

1. The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy

2. Role of the Extended Lymphadenectomy in Gastric Cancer Surgery: Experience in a Single Institution

3. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas

4. Inflammation and cancer

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rare Case of Primary Gastric Signet Ring Cell Carcinoma: a Review of Guidelines for the Management of Gastric Cancer;Indian Journal of Surgical Oncology;2023-11-25

2. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma;Saudi Journal of Gastroenterology;2023

3. Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management;World Journal of Gastrointestinal Oncology;2022-08-15

4. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis—a cohort study of 123 patients from a non-endemic country;World Journal of Surgical Oncology;2022-07-20

5. Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review;Recent Patents on Anti-Cancer Drug Discovery;2022-02